Following the Biden administration’s surprise announcement that Health and Human Services (HHS) is taking over the distribution of monoclonal antibody infusion treatments for COVID-19—reducing the number of doses by 50 percent in many red states—Florida Ron DeSantis, a government spokesman, said he had reached out to Glaxo Smith Kline to “fill the deficit”.
Some states are poised to receive lower doses of monoclonal antibody treatments after the Biden administration shut down the delivery system this week. Florida, Alabama, Texas, Tennessee are among the states targeted by HHS to restrict monoclonal antibody (mAb) doses.
“HHS will determine the amount of product each state and territory will receive on a weekly basis,” a Health Human Services spokesperson said. “State and regional health departments will later identify the sites that will receive the product and by how much. The system will help maintain a geographically and temporally equitable distribution across the country—providing consistent, equitably distributed supplies to states and territories in the coming weeks.
Noting that no reductions in treatment have been reported, Biden’s press secretary Jen Psaki was asked why the government finds it necessary to reduce the dosage in states like Florida, which need more. Saki reiterated the standard of “equity” as a reason for handling the distribution.
“Our supply is not unlimited,” Saki insisted, “and we believe it should be the same across states across the country.”
“The Biden administration did not give the Florida Department of Health or healthcare providers in Florida any notice or time to prepare for this immediate deficit,” Christina Pusha, press secretary for DeSantis’ executive office, told The Epoch Times. “There is no evidence of a national shortage of monoclonal antibody treatments, and no clear justification for rationing. The excuse given by the Biden administration was ‘equity’. Governor DeSantis spoke with Glaxo Smith Kline leadership yesterday afternoon. GSK makes its own version of the monoclonal that works in exactly the same way, if not better than Regeneron. The Fed hasn’t bought GSK supplies, only Regeneron and Eli Lilly.
Pushaw continued, “The Biden administration and their allies in the media claim Florida is using too many monoclonal treatments because of the low vaccination rate,” and Biden lashed out at Governor DeSantis for opposing the tyrannical federal vaccine mandate. is attacked. But Florida has a higher than average vaccination rate compared to other states. In Florida more than half of patients are fully vaccinated at some state monoclonal sites. They still need monoclonal antibody treatment to avoid hospitalization and death, especially if they are in high-risk groups.
At a press conference in Broward County on Thursday, DeSantis said: “We are deeply concerned by the recent sudden announcement from the Biden administration and HHS that they are going to dramatically cut the number of monoclonal antibodies that are being shipped. Florida State. Last week on September 9, President Joe Biden said his administration would increase shipments of monoclonal antibodies by 50 percent in September, and yet on September 13, HHS announced that it would take control of monoclonal antibody supplies. and it will control distribution. And then on September 14, it was announced that more than 50 percent of the monoclonal antibodies used in Florida were going to be reduced.
Pusa said HHS officials told states earlier this month that they would investigate more closely how many treatments were actually being used, but the department was not going to curtail state supplies. Was.
Biden Administration Timeline Throttling Monoclonal Distribution
Florida was informed that if it agreed to switch to “dose pack” distribution, the state could receive up to 25,000 dose packs (50,000 doses) weekly for three weeks, through September 19. Huh. The Florida Department of Health (FDOH) agreed to receive. Dose packs and vendors accepted delivery next week. To date, Florida is yet to receive 50,000 doses per week.
Health and Human Services (HHS) issued an update on the MAB ordering process, indicating that the orders will be reviewed to ensure a 70 percent utilization rate. All Florida state sites meet that limit. Therefore, the State had no reason to believe that State supplies would be cut and there was no prior indication of pending cuts from HHS.
Biden announces his way out of the pandemic: a six-pronged, comprehensive national strategy to combat COVID-19.
“The administration will increase the average weekly speed of shipment of free monoclonal antibody treatments to states by 50 percent in September, accelerating the federal government’s efforts to deliver life-saving COVID-19 treatments.”
HHS announces the federal government is taking distribution to all sites. The amount for each state will be determined by HHS.
The FDOH notified HHS of a weekly requirement of approximately 36,000 doses at only 25 state-run sites. When HHS referred to the state receiving orders for all state sites and distribution, the FDOH specifically asked whether such a shift would apply to all facilities providing treatment in the state. HHS said this was not the case and gave no indication of any upcoming limits for supplies, just that they were monitoring more closely.
HHS sent an email to all stakeholders nationwide indicating that the change in allocation strategy took place on 13 September. HHS reported that Florida’s allocation for the week of September 13 would be 3,100 doses of BAM/ETE and 27,850 doses of REGN-COV. (Two forms of antibody treatment).
“This was the first and only indication that Florida would receive short supply and would account for allocations among all facilities, contrary to HHS’s recent and previous guidance,” Pusa said.
Schemes by the numbers
Since DeSantis opened the first state-supported monoclonal treatment site in Jacksonville in mid-August:
- 25 state-run monoclonal treatment sites
- More than 90,000 treatments provided to date at state sites (this number does not count the thousands of treatments offered by other providers in Florida, such as hospitals and clinics)
- 50 percent reduction in hospital admissions from last peak
- 24 consecutive days of decline in hospital census
- The lowest number of “COVID-like illness” (CLI) in the ER reported in nearly two months (CLI is a leading indicator for COVID growth).
- HHS to 9/14 allocation: approximately 30,950 total mAb doses.
- Average demand nationwide: About 72,000 doses per week (state sites + all other providers in Florida).
- Estimated loss: 41,050
“I hope we will be able to get GSK shipments to Florida to make up for the losses,” Pusa said. “As you can see it’s a huge deficit.”
“Florida has the biggest losses but Alabama is really the worst,” Pusa said. “They don’t have any state treatment sites like ours.”
Asked whether the move to control the flow on monoclonal antibodies was an attempt to punish states with governors who would not comply with their mandates, Pusha replied, “It’s hard to say that it should be given to some states for political reasons. Not to be seen as a punishing Biden administrator.”
“I don’t know for sure and I hope it’s not true, but it looks bad, especially as HHS declined to offer any explanation beyond its public statement about ‘equity’ that How was the weekly distribution amount rationed for each state.”
Zachary Steber contributed to this report.
This News Originally From – The Epoch Times